Keytruda (Pembrolizumab) Shows Promise for Advanced Merkel Cell Carcinoma
Results of a small clinical trial show that more than half the patients with Merkel cell carcinoma, a rare but aggressive type of skin cancer, improved when they took the immunotherapy drug Keytruda (pembrolizumab).
Deadly Myths About Skin Cancer
Many people are unaware of skin cancer's dangers, and they may be underestimating their risks. Here we bust some common myths about this very common form of cancer so that you can be in the know – and protect your health.
FDA Requires Warning on Tanning Beds
The US Food and Drug Administration (FDA) says people under age 18 should not use tanning booths/beds or sunlamps, and these products will now have to carry a warning stating that. These devices have been re-classified as moderate risk (Class II) instead of low risk (Class I).